The Leadership Team at Betalin Therapeutics is responsible for setting the strategic direction and vision of the company, guiding the development of innovative cell therapy solutions for insulin-dependent diabetes. They leverage their expertise and experience to drive business growth, foster investor relations, and oversee the operational execution of the Engineered Micro-Pancreas (EMP) project, ensuring alignment with the company’s mission and objectives.
View all